Blinatumomab
Cytokine Release Syndrome and Neurological Toxicities
- Cytokine Release Syndrome (CRS), which may be life-threatening or fatal, occurred in patients receiving BLINCYTO. Interrupt or discontinue BLINCYTO as recommended.[See Dosage and Administration (2.3), Warnings and Precautions (5.1)].
- Neurological toxicities, which may be severe, life-threatening, or fatal, occurred in patientsĀ receiving BLINCYTO. Interrupt or discontinue BLINCYTO as recommended. [SeeĀ Dosage and Administration (2.3), Warnings and Precautions (5.2)
Approved Risk Evaluation and Mitigation Strategies (REMS)
Patient Counseling Information
Medication Guides
Package Inserts
Updated January 2018